| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Platin | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | sitagliptin | CTRPv2 | pan-cancer | AAC | 0.019 | 0.8 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |